icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria  april 22-26
Back grey_arrow_rt.gif
 
 
 
PRECLINICAL CHARACTERISATION OF MIV-802, A NOVEL URIDINE NUCLEOTIDE HCV NS5B POLYMERASE INHIBITOR, FOR TREATMENT OF HEPATITIS C VIRUS INFECTION
 
 
  Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
Annelie Lindqvist 1 , Helen Kylefjord 1, Horst Wähling 1, Sanja Juric 1, Staffan Torssell 1, Gennadiy Kalayanov 1, Lotta Vrang 1, Emily Hoberg 2, Claes Gustafsson 2, Matthias Gotte3, Anders Eneroth 1, Erik Lindström 1, Kristina Wikström 1, Paul Targett-Adams1, Pedro Pinho 1, Richard Bethell 1, Åsa Rosenquist* 1
1Medivir, Huddinge, Sweden. 2Dept. of Biochem and Cell Biology, University of Gothenburg, Gothenburg, Sweden. 3Department of Medical Microbiology & Immunology, University of Alberta, Edmonton (Alberta), Canada. Contact: asa.rosenquist@medivir.se

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif